Helena Smolak - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Helena Smolak's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Helena Smolak

Helena Smolak

Verified

Reporter, Real-Time EMEA News Desk, The Wall Street Journal

Barcelona

Final Covers

PovertyHomelessness

Doesn’t Cover

I never write about mens or childrens fashion.

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 1550

  • Sartorius Shares Jump After Earnings, Sales Top Views

    By Helena Smolak Verified| MarketScreener Verified By Helena Smolak Sartorius shares rose after the company specified its targets for the year given higher first-quarter earnings and sales that topped analysts' expectations. In European morning trade, shares rose 5.4% to 203.02 euros. The stock is down 6.1% so far this year. The German pharmaceutical and laboratory equipment supplier said Wednesday that it now expects its sales to increase by between 4% and 8% in 2025. It previously forecast moderate sales growth without a specific figure.

    By Helena Smolak Verified · MarketScreener

    Apr. 16, 2025

  • Haleon Acquires Chinese JV

    By Helena Smolak Verified| MarketScreener Verified By Helena Smolak Haleon entered into an agreement to fully acquire Chinese joint venture Tianjin TSKF Pharmaceuticals in a deal valued at 200 million pounds ($263.8 million), lifting its stake to 100% from 88% previously. The British consumer health company said Tuesday that it bought the last 12% equity interest in the Chinese pharma company from Tianjin Pharmaceutical Da Ren Tang.

    By Helena Smolak Verified · MarketScreener

    Apr. 15, 2025

  • Sartorius Shares Jump After Earnings, Sales Top Views

    By Helena Smolak Verified| MarketScreener Verified By Helena Smolak Sartorius shares rose after the company specified its targets for the year given higher first-quarter earnings and sales that topped analysts' expectations. In European morning trade, shares rose 5.4% to 203.02 euros. The stock is down 6.1% so far this year. The German pharmaceutical and laboratory equipment supplier said Wednesday that it now expects its sales to increase by between 4% and 8% in 2025. It previously forecast moderate sales growth without a specific figure.

    By Helena Smolak Verified · MarketScreener

    Apr. 16, 2025

As seen in

Company Info

The Wall Street Journal

The Wall Street Journal (WSJ) is a prominent American daily newspaper, established on July 8, 1889. It specializes in business, finance, and global news, making it one of the most influential newspapers in the U.S. The WSJ is owned by Dow Jones & Company, a subsidiary of News Corp, which acquired it in 2007. The WSJ publishes six days a week and offers both print and digital subscriptions. It provides comprehensive coverage of various topics, including business, finance, politics, and lifestyle. The newspaper features a well-regarded opinion section and includes special sections like Market Data, Personal Finance, and Life & Arts. With a readership that includes financial professionals, business leaders, and individual investors, the WSJ is a key resource for those seeking insights into market trends and economic policies. The WSJ has received numerous accolades for its journalism, including 39 Pulitzer Prizes, and has a significant digital presence with over 3 million digital subscribers.

New York, New York, United States

+1 609-520-4185

Founded: 1889